/Companies

Imagene

Founded 2020 · 38 employees on LinkedIn · 1 known investors

Find your way into Imagene

Sign up to see every warm intro you have to Imagene

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Imagene team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Imagene develops AI-based oncology intelligence that turns cancer data into insights to support patient care and drug development. It serves the biotech and clinical oncology market, working with scientists, physicians, and therapy developers.

Founders & leadership

Imagene was founded in 2020 by Dean Bitan, Jonathan Zalach, and Shahar Porat.

DBDean Bitan
Dean BitanCo-founder · Chief Executive OfficerHe previously founded an AI research and services company and led technology initiatives in molecular testing and precision oncology, including bioinformatics development and automated DNA extraction systems.
JZJonathan Zalach
Jonathan ZalachCDSO & Co-founderCo-founder and Chief Data Science Officer of Imagene, Jonathan Zalach has background in computer vision, machine learning, and deep learning research and technical leadership.
SPShahar Porat
Shahar PoratCTO & Co-founderShahar Porat is co-founder and CTO of Imagene, which develops AI-based oncology intelligence for cancer diagnosis and personalized therapy using histological data. He has prior experience leading technology companies and projects across various domains.

Investors · 1

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Imagene do?
Imagene develops AI-based oncology intelligence that turns cancer data into insights to support patient care and drug development. It serves the biotech and clinical oncology market, working with scientists, physicians, and therapy developers.
Who founded Imagene?
Imagene was founded by Dean Bitan, Jonathan Zalach, Shahar Porat in 2020.
Who are Imagene's investors?
Imagene's investors include Blumberg Capital.